Imperial College London
Portrait Picture

DrJonathanKrell

Faculty of Medicine, Department of Surgery & Cancer

Clinical SL in Medical Oncology (Gynaecological Oncology)
 
 
 
//

Contact

 

j.krell

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Lythgoe:2022:10.1136/jitc-2022-SITC2022.0627,
author = {Lythgoe, M and Mullish, B and Frampton, A and Dama, P and Pickford, E and Tookman, L and Cunnea, P and Fotopoulou, C and Jeffery, I and Fyvie, G and Stevenson, A and Krell, J},
doi = {10.1136/jitc-2022-SITC2022.0627},
pages = {A659--A659},
publisher = {BMJ PUBLISHING GROUP},
title = {ORAL ADMINISTRATION OF MRX0518 IN TREATMENTNAIVE CANCER PATIENTS IS ASSOCIATED WITH COMPOSITIONAL TAXONOMIC AND METABOLOMIC CHANGES INDICATIVE OF ANTI-TUMORIGENIC EFFICACY},
url = {http://dx.doi.org/10.1136/jitc-2022-SITC2022.0627},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Lythgoe,M
AU  - Mullish,B
AU  - Frampton,A
AU  - Dama,P
AU  - Pickford,E
AU  - Tookman,L
AU  - Cunnea,P
AU  - Fotopoulou,C
AU  - Jeffery,I
AU  - Fyvie,G
AU  - Stevenson,A
AU  - Krell,J
DO  - 10.1136/jitc-2022-SITC2022.0627
EP  - 659
PB  - BMJ PUBLISHING GROUP
PY  - 2022///
SP  - 659
TI  - ORAL ADMINISTRATION OF MRX0518 IN TREATMENTNAIVE CANCER PATIENTS IS ASSOCIATED WITH COMPOSITIONAL TAXONOMIC AND METABOLOMIC CHANGES INDICATIVE OF ANTI-TUMORIGENIC EFFICACY
UR  - http://dx.doi.org/10.1136/jitc-2022-SITC2022.0627
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000919423400588&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download